SynthesisFrontiers in endocrinology2025
Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis.
Tariq Alrasheed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.